[go: up one dir, main page]

MX2010008707A - Composiciones farmaceuticas de entacapona comicronizada con alcoholes de azucar. - Google Patents

Composiciones farmaceuticas de entacapona comicronizada con alcoholes de azucar.

Info

Publication number
MX2010008707A
MX2010008707A MX2010008707A MX2010008707A MX2010008707A MX 2010008707 A MX2010008707 A MX 2010008707A MX 2010008707 A MX2010008707 A MX 2010008707A MX 2010008707 A MX2010008707 A MX 2010008707A MX 2010008707 A MX2010008707 A MX 2010008707A
Authority
MX
Mexico
Prior art keywords
entacapone
sugar alcohols
micronized
pharmaceutical compositions
relates
Prior art date
Application number
MX2010008707A
Other languages
English (en)
Inventor
Kumar Jain Girish
Kapoor Ritesh
Mate Sanjay
Talwar Munish
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2010008707A publication Critical patent/MX2010008707A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas que comprenden entacapona o sus sales aceptables para uso farmacéutico, junto con uno o más alcoholes de azúcar; donde la entacapona es comicronizada con uno o más alcoholes de azúcar. La invención se refiere también a procesos para formar dichas composiciones.
MX2010008707A 2008-02-06 2009-02-06 Composiciones farmaceuticas de entacapona comicronizada con alcoholes de azucar. MX2010008707A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN264MU2008 2008-02-06
PCT/IB2009/050490 WO2009098663A1 (en) 2008-02-06 2009-02-06 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols

Publications (1)

Publication Number Publication Date
MX2010008707A true MX2010008707A (es) 2011-03-25

Family

ID=40626966

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008707A MX2010008707A (es) 2008-02-06 2009-02-06 Composiciones farmaceuticas de entacapona comicronizada con alcoholes de azucar.

Country Status (20)

Country Link
US (1) US8728517B2 (es)
EP (1) EP2293791B1 (es)
JP (1) JP5651478B2 (es)
KR (1) KR101532810B1 (es)
CN (1) CN101939002B (es)
AT (1) ATE534382T1 (es)
AU (1) AU2009211030B2 (es)
BR (1) BRPI0907727A2 (es)
CA (1) CA2714113C (es)
CY (1) CY1116484T1 (es)
DK (1) DK2293791T3 (es)
ES (1) ES2377597T3 (es)
HR (1) HRP20120106T1 (es)
MX (1) MX2010008707A (es)
NZ (1) NZ587169A (es)
PL (1) PL2293791T3 (es)
PT (1) PT2293791E (es)
RU (1) RU2010136934A (es)
SI (1) SI2293791T1 (es)
WO (1) WO2009098663A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
CN106880607A (zh) * 2015-12-15 2017-06-23 北大方正集团有限公司 一种含有瑞戈非尼的口腔崩解片及其制备方法
CN115715767B (zh) * 2022-11-02 2023-06-09 石家庄四药有限公司 一种恩他卡朋片剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
FI109453B (fi) * 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
EA013161B1 (ru) * 2005-06-08 2010-02-26 Орион Корпорейшн Дозированная форма для перорального применения
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent

Also Published As

Publication number Publication date
EP2293791B1 (en) 2011-11-23
WO2009098663A1 (en) 2009-08-13
CA2714113C (en) 2015-11-24
ATE534382T1 (de) 2011-12-15
AU2009211030A1 (en) 2009-08-13
CN101939002A (zh) 2011-01-05
KR101532810B1 (ko) 2015-06-30
JP5651478B2 (ja) 2015-01-14
NZ587169A (en) 2011-03-31
RU2010136934A (ru) 2012-03-20
ES2377597T3 (es) 2012-03-29
US8728517B2 (en) 2014-05-20
CN101939002B (zh) 2012-12-26
JP2011526241A (ja) 2011-10-06
BRPI0907727A2 (pt) 2017-06-13
SI2293791T1 (sl) 2012-03-30
AU2009211030B2 (en) 2013-12-05
HRP20120106T1 (hr) 2012-02-29
US20110052681A1 (en) 2011-03-03
EP2293791A1 (en) 2011-03-16
KR20100117096A (ko) 2010-11-02
PL2293791T3 (pl) 2012-04-30
PT2293791E (pt) 2012-01-11
CA2714113A1 (en) 2009-08-13
DK2293791T3 (da) 2012-02-13
CY1116484T1 (el) 2017-03-15

Similar Documents

Publication Publication Date Title
PH12016500216A1 (en) Stable pharmaceutical composition and methods of using same
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
EP3699176A3 (en) Antiviral compounds
IN2012DN02441A (es)
GT201300165A (es) Compuestos y su uso como inhibidores de bace
WO2010139979A3 (en) Processes for preparing crystalline forms of dasatinib
PH12013501143A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
MX2011008171A (es) Composicion farmaceutica que comprende linagliptina y opcionalmente un inhibidor de sglt2, y usos de la misma.
UA105229C2 (uk) Фармацевтичний склад
WO2010092090A3 (en) Novel salts of sitagliptin
ZA201005615B (en) Pharmaceutical compositions of entacapone,levodopa and carbidopa with improved bioavailability
WO2011025286A3 (ko) 리포테이코익산 유래 당지질 및 이를 포함하는 조성물
WO2009118589A3 (en) Orally disintegrating compositions of rhein or diacerein
WO2011048563A3 (en) Orally disintegrating tablets of betahistine
WO2012101653A3 (en) Modified release pharmaceutical compositions memantine
WO2008035380A3 (en) An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2010065586A3 (en) Preparation of capecitabine
MX339361B (es) Derivados de alternano.
HK1201067A1 (en) Sialic acid analogs
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
SI2293791T1 (sl) Farmacevtski sestavki entakapona mikroniziranegaskupaj s sladkornimi alkoholi
WO2011027359A3 (en) Process for the preparation of 4 -hydroxy atomoxetine and intermediates in the manufacture thereof
EP2428202A3 (en) Orally disintegrating compositions

Legal Events

Date Code Title Description
FG Grant or registration